In the meantime, EA improved cognitive decline, possibly targeted at the transmembrane protein 126A (TMEM126A) and the excitatory amino acid transporters (SLC1A2/EAAT2) in rats with neuropathic pain [264]. The gene discussed is TMEM126A; the disease is Mental deterioration.